Scientific
Publications
Online Resources
Central
Venous Catheters for Dialysis (CVCDs)
Catheter Related Bloodstream Infection (CRBSI) |
Includes Internal Reference Numbers
Sorbent Based Dialysis Systems;
BioLogic-HD System, Renal Solutions SHD
Sorbent Suspension Dialysis System; the
Biologic-DT System, Liver Dialysis Unit
Sorbent
Based Pheresis; the BioLogic-DTPF System
Whole
Body Hyperthermia; BioLogic-HT System, ThermoChem System
Sorbent
Based Dialysis Systems; BioLogic-HD System, Renal Solutions SHD
Journal Articles
HD1 |
Sinclair A, Babbs CF, Griffin DD
and Ash SR. Roux-Y intestinal bypass for administration of
sorbents in uremia. Kidney Int Suppl 13(88):S153-S159,
1978. |
HD2 |
Sinclair A, Griffin DD, Voreis
and Ash SR. Sorbent binding of urea and creatinine in a Roux-Y
intestinal segment. Clin Nephrol 11(2):97-104, 1979. |
HD3 |
Ash SR, Barile RG, Thornhill JA,
Sherman JD, and Wang N-HL. In vivo evaluation of calcium-loaded
zeolites and urease for urea removal in hemodialysis. Trans
Am Soc Artif Inter Organs 26:111-115, 1980. |
HD4 |
Wang N-HL, Kessler DP and Ash SR.
Mass transfer characteristics of a sorbent-based reciprocating
dialyzer. Chem. Eng. Commun 5(5):347-365,
1980. |
HD5 |
Ash SR, Barile RG, Wilcox PG, Wright
DL, Thornhill JA, Dhein CR, Kessler DP, and Wang N-HL. The
sorbent suspension reciprocating dialyzer: a device with minimal
sorbent saturation. ASAIO J 4(1):28-40, 1981. |
HD6 |
Barile RG, Wang N-HL, Blake DE,
Belcastro PF, Gupta S, Regnier FE, Thornhill JA, Kessler DP,
and Ash SR. A reciprocating, single-needle hemodialyzer with
bidirectional flow of sorbent suspension. Artif Organs 6(3):267-279,
1982. |
HD7 |
Badylak S, Ash SR, Thornhill JA,
Carr DJ. Doppler ultrasonic detection of particulate release
during hemodialysis with cellulose hollow-fiber and sorbent
suspension reciprocating dialyzers. Artif Organs 8(2):220-223,
1984. |
HD8 |
Davidson GW, Ash SR, et al. Assessment
of biomaterials as components of a reciprocating dialyser during
canine dialysis. Biomaterials 5(4):227-233, 1984. |
HD9 |
Ash SR, Barile RG, Wilcox PG, Wright
DL, Thornhill JA, Dhein CR, Kessler DP and Wang N-HL. The sorbent
suspension reciprocating dialyzer: a device with minimal sorbent
saturation. ASAIO J 4:28-40, 1984. |
HD10 |
Winchester JF and Ash SR. Hemoperfusion
for uremia: past, present, future. Kidney Int Suppl 17:S127-S130,
1985. |
HD11 |
Ash RS, Carr DJ, Baker K, Schultz
TW and Reynolds LO. Automatic priming, blood flow control,
and rinsing during single access hemodialysis. Trans Am
Soc Artif Inter Organs 31:499-503, 1985. |
HD12 |
Ash SR, Carr DJ, and Blake DE.
Sorbent chemicals in hemodialysis and medicine. Proc Materials
Research Society on Biomedical Materials Boston, 1987. |
HD13 |
Ash SR, Baker K, Blake DE, Carr
DJ, Echard TG, Sweeney KD, Handt AE and Wimberly AL. Clinical
trials of the BioLogic-HT - automated single access sorbent-based
dialysis. ASAIO Trans 33(3):524-531, 1987. |
HD14 |
Ash SR, Blake DE, Carr DJ, Baker
K and Echard TG, The BioLogic-HD: hemodialysis simplified. Proc
Intl Symposium Artif Organs pp. 263-277, 1986. |
HD15 |
Koszuta JJ, Carter JM and Ash SR.
Effect of ethanol perfusion on creatinine removal in a Roux-Y
intestinal segment. Intl J Artif Organs 14(7):417-423,
1991. |
HD16 |
Ash, SR. The Allient™ Dialysis
System. Seminars in Dialysis, 2004 17(2):164-5. |
HD17 |
Rosenbaum BP, Ash SR, Carr DJ.
Predicting dialysate sodium composition in kidney dialysis
using single point and multiple-dilution conductivity measurement.
Submitted to ASAIO Journal 5/05, with positive reviews. |
Abstracts
SHD-A0 |
Ash SR, Carr DJ, Blake DE, Truitt
RB. Simpler, safer, more automated equipment for night-time
home hemodialysis. PDI 19; Suppl 1: S87, 1999. |
SHD-A1 |
Ash SR, Carr DJ, Harker KD, Truitt
RB, Korkor AB. Simple, safe, single-lumen system for long duration
dialysis. Blood Purif 18:74, 2000. |
SHD-A2 |
Ash SR, Carr DJ, Harker KD, Truitt
RB, Korkor AB. Simpler, safer, more-automated equipment for
nighttime home hemodialysis. PDI 20 (Suppl 1):S101,
2000. |
SHD-A3 |
Ash SR, Carr DJ, Harker K, Truitt
RB, Korkor A. Every-other night hemodialysis (QOHD) with plate
dialyzer as blood pump and single-lumen access. ASAIO J 46:223,
2000. |
SHD-A4 |
Ash SR, Carr DJ, Harker K, Truitt
RB, Korkor AB. Every-other night hemodialysis with single-lumen
access, plate dialyzer as blood pump, and sorbent column (SHD). Int
J Artif Organs 32:575, 2000. |
Home Hemodialysis
- Related Articles and Abstracts
SHD-R1 |
Kjellstrand CF. Interview with
an expert: Daily home hemodialysis: Is longer, more frequent
dialysis a ‘sleeping beauty’ waiting to awaken? Nephrology
Incite, Summer 2000. |
SHD-R2 |
Roberts M. Conference Report. 20th
annual conference on peritoneal dialysis; 6th international
symposium on home hemodialysis. Dialysis & Transplantation
29:555-558, 2000. |
Sorbent Suspension Dialysis System;
the Biologic-DT System, Liver Dialysis Unit
Liver Failure – Journal
Articles
DT-L1 |
Ash SR. Treatment of acute hepatic
failure with encephalopathy: a review. Int J Artif Organs 14(4):191-195,
1991. |
DT-L2 |
Ash SR, Blake DE, Carr DJ, Carter
C, Howard T, Makowka L. Neurologic improvement of patients
with hepatic failure and coma during sorbent suspension dialysis. ASAIO
Trans 37(3):M332-M334, 1991. |
DT-L3 |
Ash SR, Blake DE, Carr DJ, Carter
C, Howard T and Makowka L. Clinical effects of a sorbent suspension
dialysis system in treatment of hepatic coma (the BioLogic-DT). Int
J Artif Organs 15(3):151-161, 1992. |
DT-L4 |
Ash SR, Carr DJ, Blake DE, Rainier
JB, Demetriou AA, Rozga J. Effect of sorbent-based dialytic
therapy with the Biologic-DT on an experimental model of hepatic
failure. ASAIO J 39(3):M675-M680, 1993. |
DT-L5 |
Ash SR, Hemodiabsorption in treatment
of acute hepatic failure and chronic cirrhosis with ascites. Artif
Organs 18(5):355-362,1994. |
DT-L6 |
Ash SR, Hemodiabsorption in the
treatment of acute hepatic failure. ASAIO J 40(1):80-82,
1994. |
DT-L7 |
Wilkinson AH, Ash SR, Nissenson
AR. Hemodiabsorption in treatment of hepatic failure. Journal
of Transplant Coordination 8:43-50, 1998. |
DT-L8 |
Ash SR. Letter to the Editor. Artif
Organs 22(6):518-519, 1998. |
DT-L10 |
Ash SR. Overview of the treatment
of fulminant hepatic failure. 2000 UpToDate, Burton Rose Editor. |
Liver Failure
- Abstracts
DTL-A1 |
Ash SR, Wilkinson AH, Hughes RD,
Williams R. BioLogic-DT System in treatment of acute hepatic
coma; results of randomized prospective controlled trials. American
Society for Artif Organs. 42(2)11, March-April 1996. |
DTL-A2 |
Ash SR, Patzer JF, Carr DJ, Blake
DE. Push-pull sorbent-based pheresis in treatment of acute
hepatic failure with coma (AHF). Amer. Soc. for Artificial
Internal Organs. 43(2):18, March-April 1997. |
DTL-A3 |
Ash S, Wilkinson A, Hughes R, Williams
R. BioLogic-DT system in treatment of acute hepatic coma; results
of randomized, prospectively controlled trials. J Hepatology 25(1):101,
1996. |
DTL-A4 |
Mazariegos GV, Ash SR, Patzer JF.
Preliminary results: randomized clinical trial of the BioLogic-DT
in treatment of acute hepatic failure (AHF) with coma. Artif
Organs 21(6):529, 1997. |
DTL-A5 |
Mazariegos GV, Kramer DK, Linden
P, Pinna A, Fung JJ, Ash SR, Patzer JF. Treatment of hepatic
failure with advanced encephalopathy using the BioLogic-DT:
Preliminary clinical results. Critical Care Society,
1998. |
DTL-A6 |
Ash SR, Leamon KD, Gingrich CH.
Hemodiabsoption (The BioLogic-DT System) in treatment of hepatic
failure with encephalopathy: Summary of randomized, prospectively
controlled clinical trials. Hepatology 28(4, Pt. 2):497A,
1998. |
DTL-A7 |
Ash SR, Kuczek T, Foster DE, Blake
DE, Gingrich CH. Hemodiabsorption in treatment of hepatic failure:
summary of randomized, prospectively controlled clinical trials
with the BioLogic-DT System. ASAIO J 45:202, 1999.
(Slide Presentation ASAIO `99.) |
DTL-A8 |
Ash SR, Kuczek T, Foster DE, Blake
DE, Gingrich CH, Mankus RA. Hemodiabsorption in treatment of
hepatic and hepatorenal failure: summary of randomized, prospectively
controlled clinical trial. J Am Soc Nephrol 10:628A,
1999. |
DTL-A9 |
Ash SR, Kuczek T, Foster DE, Blake
DE, Gingrich CH. Hemodiabsorption in treatment of hepato-renal
failure: Summary of randomized, prospectively controlled clinical
trials. Hepatology 30:169A, 1999. |
DTL-A10 |
Ash SR, Kuczek T, Foster DE, Blake
DE, Gingrich CH. Liver dialysis in treatment of hepatic failure
and hepatorenal failure: Summary of randomized, prospectively
controlled clinical trials. Blood Purif 18:67, 2000. |
DTL-A11 |
Ash SR, Kuczek T, Blake DE, Gingrich
CH. Liver dialysis in treatment of hepatorenal failure: randomized
clinical trials and clinical experience. ASAIO J 46:223,
2000. |
DTL-A12 |
Ash S, Kuczek T, Foster D, Steczko
J, Blake D, Gingrich C. Liver dialysis in treatment of hepatic
failure and hepatorenal failure: randomized clinical trials
and recent improvements. Int J Artif Organs 23:534,
2000. |
DTL-A13 |
Ash SR, Kuczek T, Steczko J, Blake
DE, Gingrich CH. Randomized clinical trials of liver dialysis
in treatment of hepatic failure and hepatorenal failure.
J Am Soc Nephrol 11:173A, 2000. |
DTL-A14 |
Ash SR, Blake DE, Carr DJ, Harker
KD, Levy H. Push-pull sorbent-based pheresis and hemodiabsorption
in treatment of hepatic failure: preliminary results of a clinical
trial. Ther Apher 4:423, 2000. (Abstract #36) |
DTL-A15 |
Ash SR, Kuczek T, Steczko J, Blake
DE, Gingrich CH. Randomized clinical trials of liver dialysis
in treatment of hepatic failure and hepatorenal failure. Ther
Apher 4:421, 2000. (Abstract #27) |
Liver Failure
- Related Articles and Abstracts
DT-R0 |
Hughes RD, Pucknell A, Routley
D, Langley PG, Wendon JA, Williams R. Evaluation of the BioLogic-DT
sorbent-suspension dialyser in patients with fulminant hepatic
failure. Int J Artif Organs 17(12):657-662, 1994. |
DT-R1 |
Kaplan AA, Epstein M. Extracorporeal
blood purification in the management of patients with hepatic
failure. Seminars in Neph 17(6):576-582, 1997. |
DT-R2 |
Whitehead T, Beck D, Ramachandran
R. Lowell J, Shenoy S, Howard T. Bioreactor for extracorporeal
liver assist device (ELAD). ASAIO J 44(2):92A, 1998. |
DT-R3 |
Whitehead TD, Lowell JA. Bioreactor
for extracorporeal liver assist device for prolonged treatments. Hepatology 26(4):168A,
1997. |
DT-R4 |
Ellis AJ, Hughes RB, Nicholl D,
Langley PG, Wendon JA, O’Grady JG, Williams R. Temporary
extracorporeal liver support for severe acute alcoholic hepatitis
using the BioLogic-DT. Int J Artif Organs 22(1):27-34,
1999. |
DT-R5 |
Kramer L, Gendo A, Madl C, Mullen
K, Kaminski-Russ K, Zauner C, et al. A controlled study of
the BioLogic-DT System in chronic hepatic encephalopathy. Hepatology 28(4,
Pt. 2):401A, 1998. |
DT-R6 |
Jeyaraj P. The bio-artificial liver.
Liver Update ’99. Selangor, Malaysia. Pg. 28. |
DT-R7 |
Kramer L, Gendo A, Madl C, Ferrara
I, Funk G, Schenk P, Sunder-Plassmann G, Horl WH. Biocompatibility
of a cuphrophane charcoal-based detoxifier device in cirrhotic
patients with hepatic encephalopathy. Am J Kidney Dis 36:1193-2000,
2000. |
DT-R8 |
Huang K-W, Ko W-J, Lee P-H, Lai
M-Y. Improvement of hepatic encephalopathy following treatment
of fulminant hepatic failure with extracorporeal blood detoxification.
3rd World Congress of International Society for Apheresis (ISFA).
January 11-14, 2001, Taipei, Taiwan. Proceedings, Page 81. |
DT-R9 |
Po W-J, Lee P-H, Lai M-Y. Outcome
of Biological-DT treatment of patients with fulminant hepatic
failure. 3rd World Congress of International Society for Apheresis
(ISFA). January 11-14, 2001, Taipei, Taiwan. Proceedings, Page
47. |
DT-R10 |
Kraus MA. Post-market experience
of the HemoTherapies Unit™ for liver dialysis extracorporeal
liver-support therapy. (6th International Conference on CRRT) Blood
Purif 19:331; 2001. |
DT-R11 |
Stribling R, Ghalib RH, Duchini
A, Seu P, Goss JA. Improvement in respiratory status and quality
of life after liver dialysis treatment of hepatic encephalopathy
in critically ill cirrhotic patients. Hepatology 34:659A,
2001. |
DT-R12 |
Stribling R, Ghalib RH, Duchini
A, Seu P, Goss J. Reversal of stage 3 hepatic encephalopathy
in therapy-resistant critically ill cirrhotic patient: the
impact of liver dialysis with the HemoTherapies Unit. Hepatology 34:660A,
2001. |
DT-R13 |
Stuart M. Liver Assist Devices:
Proof of Life. Startup 7; 3: 19-28, 2002. |
DT-R14 |
Hillebrand DJ, Hill K, Hu KQ, Cottrell
A, Teichman S. Formal heparin anticoagulation protocol improves
safety of charcoal-based liver assist treatments. ASAIO
Journal 48;2: A 186, 2002 |
DT-R15 |
Falkenhagen D, Strobl W, Hartmann
J, Schrefl A, Linsberger I, Kellner KH, Aussenegg F, Leitner
A. Patient Safety Technology for microabsorbent systems in
extracorporeal blood purification. Artificial Organs 26
(2): 84-90, 2002 |
DT-R16 |
Huang KW, Chao A, Chou NK, Ko WJ.
Hepatic encephalopathy and cerebral blood flow improved by
liver dialysis treatment. Int J of Artific Organs 26
(2): 149-151, 2003 |
DT-R17 |
Patzer JF. Bound Solute Dialysis. ASAIO
Journal 49 (3): 271-281, 2003. |
DT-R18 |
Davenport A. Extracorporeal support
for patients with hepatic failure. Hemodialysis International 7(3):
256-263, 2003. |
DT-R19 |
Hillebrand DJ, Hill KB, Hu KQ,
Strutt M, Wilson B, Cottrell A, Teichman S, Hay K, Bull B.
Formal heparin anticoagulation protocol improves safety of
charcoal-based liver assist treatments. ASAIO J, pending
2003. |
DT-R20 |
Kjaergard LL, Liu J, Als-Nielsen
B, Gluud C. Artificial and Bioartificial support systems for
acute and acute-on-chronic liver failure. JAMA 289(2);
2003, p 217-222. |
DT-R21 |
Aladag M, Gurakar A, Jalil S, Wright
H, Alamian S, Rashwan S, Sebastian A, Nour B. A liver transplant
experience with Liver Dialysis in the management of patients
with fulminant hepatic failure: a preliminary report. Transplantation
Proceedings; 36, 2004. |
DT-R22 |
Jones SKB (RN), When the liver
fails. www.rnweb.com, Vol
66, No. 11, 32-36, November 2003 |
DT-R23 |
Akdodan M, El-Sahwi K, Ahmed U,
Rashwan S, Sebastian A, Wright H, Nour B, Gurakar A. Experience
with liver dialysis in acetaminophen induced fulminant hepatic
failure; a preliminary report. Turkish Journal of Gastroenterology 2003,
V 14, No 3, Page 164-167. |
DT-R24 |
El-Sahwi K, Karim S, Akdodan M,
Ahmed U, Monlux R, Rashwan S, Smith C, Wright H, Sebastian
A, Nour B, Gurakar A. The impact of total plasma exchange
and/or liver dialysis on the management of acute hepatic encephalopathy. Gastroenterology 123:
2002, p55 (a) . |
DT-R25 |
Hill K, Hu KQ, Cottrell A, Teichman
S, Hillebrand DJ. Charcoal-based hemodiabsorption liver support
for episodic type C hepatic encephalopathy. Am J of Gastroenterology 2003:
98(12); 2763-2770. |
DT-R26 |
Hillebrand DJ, Hill K, Hu KQ, et
al. Formal Heparin Anticoagulation Protocol Improves Safety
of Charcoal-Based Liver Assist Treatments. ASAIOJ 2002;48:186 |
Drug Overdose – Journal
Articles
DT-D1 |
Shihab-Eldeen AA, Peck GE, Ash
SR, Kaufman GM. Evaluation of the sorbent suspension reciprocating
dialyser in the treatment of overdose of paracetamol and phenobarbitone. J
Pharm Pharmacol 40:381-387, 1988. |
DT-D2 |
Ash SR, Blake DE, Carr DJ. Increasing
selectivity of chemical removal from blood by pre-loading charcoal
of the BioLogic-DT. American Filtration Society 7:329-332,
1993 |
DT-D3 |
Ash SR, Blake DE, Carr DJ, Rainier
JB, Gingrich CH, Truitt RB. Selective chemical removal from
blood by a sorbent suspension dialysis system (Biologic-DT). American
Filtration Society 7:325-328, 1993. |
DT-D4 |
Ash SR, Levy H, Akmal M, Mankus
RA, Sutton JM, Emery DR, Scanlon JC, Blake DE, Carr DJ. Treatment
of severe tricyclic antidepressant overdose with extracorporeal
sorbent detoxification. Advances in Renal Replacement Therapy 9:31-41,
2002. |
DT-D5 |
Ash SR, Caldwell CA, Singer GG,
Lowell JA, Howard TK, Rustgi VK. Treatment of acetaminophen-induced
hepatitis and fulminant hepatic failure with extracorporeal
sorbent-based devices. Advances in Renal Replacement Therapy 9:42-53,
2002. |
Drug Overdose
- Abstracts
DTD-A1 |
Ash SR, Rustgi VK. Recovery of
hepatic function following treatment of acetaminophen overdose
with the BioLogic-DT. Abstract #348, pg. A-88. Proceeding from
Digestive Disease Week. May 1997. |
DTD-A2 |
Lowell JA, Caldwell CA, Singer
G, Rustgi VK, Ash SR, Wendon JA, Williams R. Treatment of acetaminophen-induced
hepatotoxicity and fulminant hepatic failure by the BioLogic-DT® System. Hepatology 26:4(2):252A,
1997. |
DTD-A3 |
Ash SR, Caldwell CA, Singer GG,
Lowell JA, Howard TK, Rustgi VK, Hughes R, Ellis T, Wendon
JA, Williams R. Treatment of acetaminophen-induced hepatitis
and fulminant hepatic failure by the BioLogic-DT system. ASAIO
J 45:204, 1999. (Poster presentation at ASAIO `99.) |
DTD-A4 |
Mankus RA, Ash SR, Levy H, Akmal
M, Blake DE, Carr DJ, Emery DR, Scanlon JC. Treatment of severe
tricyclic antidepressant (TCA) overdose using hemodiabsorption
by the BioLogic-DT system. ASAIO J 45:123, 1999. (Poster
presentation at ASAIO `99.) |
DTD-A5 |
Ash SR, Levy H, Akmal M, Mankus
RA, Sutton JM, Emery DR, Scanlon JC, Blake DE, Carr DJ. Treatment
of severe tricyclic antidepressant overdose with the BioLogic-DT
System. J Am Soc Nephrol 10:628A, 1999. |
DTD-A6 |
Ash SR, Caldwell CA, Singer GG,
Lowell JA, Howard TK, Rustgi VK. Treatment of acetaminophen-induced
hepatitis and fulminant hepatic failure by the BioLogic-DT
System. Hepatology 30:552A, 1999. |
Sorbent Based
Pheresis; the BioLogic-DTPF System
Liver Failure – Journal
Articles
PF-L1 |
Ash SR, Blake DE, Carr DJ, Harker
KD. Push-pull sorbent-based pheresis for treatment of acute
hepatic failure: The BioLogic-detoxifier/plasma filter System. ASAIO
J 44(3):129-139, 1998. |
PF-L2 |
Ash SR, Knab WR, Blake DE, Carr
DJ, Steczko J, Harker KD, Levy H. Push-pull sorbent-based pheresis
and hemodiabsorption in treatment of hepatic failure: preliminary
results of a clinical trial with the BioLogic-DTPF System. Therapeutic
Apheresis 4:218-228, 2000. |
PF-L3 |
Steczko J, Bax KC, Ash SR. Effect
of hemodiabsorption and sorbent-based pheresis on amino acid
levels in hepatic failure. Int J Artificial Organs 6:375-388
2000. |
PF-L4 |
Ash SR. Powdered Sorbent liver
dialysis and pheresis in treatment of hepatic failure. Therapeutic
Apheresis 5(5):404-416, 2001. |
PF-L5 |
Ash SR. Extracorporeal blood detoxification
by sorbents in treatment of hepatic encephalopathy. Advances
in Renal Replacement Therapy 9:3-18, 2002. |
Liver Failure
- Abstracts
PFL-A1 |
Ash SR, Carr DJ, Blake DE, Harker
KD. Push-pull sorbent-suspension pheresis for treatment of
acute hepatic failure: the BioLogic-DTPF. ASAIO J 42(2):11,
1996. |
PFL-A2 |
Ash SR, Knab WR, Steczko J, Carr
DJ, Blake DE. Hepatic failure treatment by powdered sorbent
pheresis - the BioLogic-DTPF System. ASAIO J 44(2):92A,
1998. |
PFL-A3 |
Ash SR, Knab WR, Blake DE, Carr
DJ, Harker DK, Levy H. The BioLogic-DTPF System in treatment
of fulminant hepatic failure: preliminary results of a clinical
trial. Hepatology 28(4, Pt. 2):496A, 1998. |
PFL-A4 |
Ash SR, Blake DE, Carr DJ, Harker
KD, Levy H. Push-pull sorbent-based pheresis (BioLogic-DTPF)
in treatment of hepatic failure: preliminary results of a clinical
trial. ASAIO J 45:203, 1999. (Poster presentation
at ASAIO `99). |
PFL-A5 |
Steczko J, Ash SR, Bax KC, Blake
DE. Amino acid profiles during hepatic failure during sorbent-based
dialysis and sorbent-based pheresis treatment. Presented at
10th International Symposium on Hepatic Encephalopathy and
Nitrogen Metabolism, Turkey, 1999. |
PFL-A6 |
Ash SR, Blake DE, Carr DJ, Harker
KD, Levy H. Push-pull sorbent-based pheresis (BioLogic-DTPF
System) in treatment of hepatic failure: preliminary results
of a clinical trial. Presented at for 10th International Symposium
on Hepatic Encephalopathy and Nitrogen Metabolism, Turkey,
1999. |
PFL-A7 |
Ash SR, Blake DE, Carr DJ, Harker
KD, Levy H. Push-pull sorbent-based pheresis (BioLogic-DTPF
System) in treatment of hepatic failure: preliminary results
of a clinical trial. Therapeutic Apheresis 3(2):113,
1999. |
PFL-A8 |
Ash SR, Bax KC, Steczko J. Changes
in plasma amino acid levels in hepatic failure patients during
sorbent-based dialysis and sorbent-based pheresis treatment. Hepatology 30:675A,
1999. |
PFL-A9 |
Ash SR, Blake DE, Carr DJ, Harker
KD, Levy H. Push-pull sorbent-based pheresis and hemodiabsorption
in treatment of hepatic failure: preliminary results of a clinical
trial. 3rd World Congress of International Society for Apheresis
(ISFA). January 11-14, 2001, Taipei, Taiwan. Proceedings, Page
48. |
Liver Failure
- Related Articles and Abstracts
PFL-R1 |
Whitehead TD, Lowell JA, Mohanakumar
T, Beck DJ, Ramachandran PA, Shenoy S, Howard TK. Bioreactor
for extracorporeal liver assist device for prolonged treatments. Hepatology 26(4):168A,
1997. |
Sepsis – Journal
Articles
PF-S1 |
Levy H, Ash SR, Knab WR, Steczko
J, Carr DJ, Blake DE. Systemic inflammatory response syndrome
(SIRS) treatment by powdered sorbent pheresis: the BioLogic-Detoxification
Plasma Filtration System. ASAIO J 44(5):M659-M665,
1998. |
PF-S2 |
Steczko J, Ash SR, Blake DE, Carr
DJ, Bosley RH. Cytokines and endotoxin removal by sorbents
and its application in push-pull sorbent-based pheresis: The
BioLogic-DTPF System. Artif Organs 23:310-318, 1999. |
PF-S3 |
Ash SR, Steczko J, Levy H, Blake
DE, Carr DJ. Treatment of systemic inflammatory response syndrome
by push-pull powdered sorbent pheresis: A Phase I clinical
trial. Therapeutic Apheresis 5 (6):497-505, 2001 |
PF-S4 |
Peter AT, Ash SR, Steczko J, Turek
JJ, Blake DE, Carr DJ, Knab WR, Bosley RH. Push-pull sorbent-based
pheresis treatment in an experimental canine endotoxemia model:
preliminary report. Intern J Artif Organs 22:177-188,
1999. |
Sepsis - Abstracts
PFS-A1 |
Steczko J, Ash SR, Carr DJ, Blake
DE. Cytokine removal from plasma by push-pull sorbent-based
pheresis (the BioLogic-DTPF System). ASAIO J 43(2):82,
1997. |
PFS-A2 |
Ash SR, Steczko J, Carr DJ, Blake
DE. Cytokine, endotoxin, and bilirubin removal from plasma
by push-pull sorbent-based pheresis (the BioLogic DTPF System). Artif
Organs 21(6):499, 1997. |
PFS-A3 |
Ash SR, Steczko J, Carr DJ, Blake
DE. Cytokine and bilirubin removal in acute hepatic failure
by push-pull sorbent-based pheresis (the BioLogic-DTPF System). Hepatology 26(4p2):475A,
1997. |
PFS-A4 |
Steczko J, Ash SR, Levy H, Carr
DJ, Blake DE. Cytokine removal from plasma of patients with
sepsis by the BioLogic-DTPF System. Hepatology 26:4(2):604A,
1997. |
PFS-A5 |
Levy H, Ash SR, Knab WR, Steczko
J, Carr DJ, Blake DE. Systemic inflammatory response syndrome
(SIRS) treatment by powdered sorbent pheresis: the BioLogic-DTPF
System. ASAIO J 44(2):81A, 1998. |
PFS-A6 |
Levy H, Ash SR, Steczko J, Carr
DJ. Cytokine removal from plasma of patients with SIRS by the
BioLogic-DTPF. Poster presentation at 18th International Symposium. Critical
Care 2(1), March 1998. |
PFS-A7 |
Ash SR, Levy H, Mankus RA, Knab
WR, Steczko J, Carr DJ, Blake DE. Treatment of systemic inflammatory
response syndrome (SIRS) by powdered sorbent pheresis: the
BioLogic-DTPF System. J Am Soc Nephrol 9:471A, 1998. |
PFS-A8 |
Levy H, Ash SR, Knab WR, Steczko
J, Carr DJ, Blake DE. Treatment of systemic inflammatory response
syndrome (SIRS) by powdered sorbent pheresis: the BioLogic-DTPF
System. Hepatology 28(4, Pt.2):225A, 1998. |
PFS-A8 |
Ash SR, Levy H, Steczko J, Carr
DJ, Blake DE. Push-pull sorbent-based pheresis (BioLogic-DTPF
System) in treatment of systemic inflammatory response syndrome
(SIRS). Therapeutic Apheresis 3(2):113, 1999. |
PFS-A9 |
Ash SR, Levy H, Steczko J, Carr
DJ, Blake DE. Push-pull sorbent-based pheresis and liver dialysis
in treatment of SIRS (Inflammatory Response Syndrome) 3rd World
Congress of International Society for Apheresis (ISFA). January
11-14, 2001, Taipei, Taiwan. Proceedings, Page 102. |
Whole
Body Hyperthermia; BioLogic-HT System, ThermoChem System
Hyperthermia – Journal
Articles
HT-1 |
Steinhart CR, Ash SR, Gingrich
C, Sapir D, Keeling GN, Yatvin MB. Effect of whole body hyperthermia
on AIDS patients with Kaposi’s sarcoma: a pilot study. J
Acquired Deficiency Syndromes and Human Retrovirology 11(3):271-281,
1996. |
HT-2 |
Ash SR, Steinhart CR, Curfman MF,
et al. Extracorporeal whole body hyperthermia treatments for
HIV infection and AIDS. ASAIO J 43(5):M830-M838, 1997. |
Hyperthermia
Abstracts
HT-A1 |
Ash SR, Steinhart CR, Curfman MF,
Gingrich CH, Sapir DA, Yatvin MB. Whole body hyperthermia treatments
for AIDS; a randomized, controlled trial. American Society
for Artif Organs 42(2):98, 1996. |
HT-A2 |
Yatvin MB, Shenoy M, Li W, Steinhart
C, Ash SR, Gingrich C, Sapir D, Keeling, G. Whole-body hyperthermia
to treat HIV-infection. 5th Annual AIDS Day Conference, Munich,
Germany, January 1996. |
HT-A3 |
Ash SR, Steinhart CR, Curfman MF,
Gingrich CH, Sapir DA, Yatvin MB. Whole body hyperthermia treatments
for AIDS; combination with protease inhibitor therapy. Amer.
Soc. for Artificial Internal Organs. 43(2):34, 1997. |
HT-A4 |
Ash S, Steinhart C, Curfman M,
Gingrich C, Sapir D, Yatvin M. Whole body hyperthermia treatment
(WBHT) for AIDS: a randomized, controlled study in patients
with drug treatment failure. Artif Organs 21(6):567,
1997. |
Hyperthermia - Related Articles and Abstracts
HT-R1 |
Zwischenberger JB, Woodson L, Vertrees
RA, Bidell E, Deyo DJ, Chernin J, Graves D, Bidani A. Perfusion-induced
systemic hyperthermia for advanced non-small cell lung cancer:
initial clinical experience. Abstract submitted for AACR Annual
Meeting, 1999. |
HT-R2 |
Zwischenberger JB, Vertrees RA,
Woodson LC, Bedell EA, Alpard SK, McQuitty C, Chernin JM. Percutaneous
veno-venous perfusion-induce4d systemic hyperthermia for advanced
non-small cell lung cancer: initial clinical experience. Pending
publication, presented at American Association for Cancer research,
4/99, Philadelphia, PA. |
|